1.
|
Phase: Phase III Type: Prevention Status: Active Age: 40 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000353185, P30CA023074, UARIZ-00-0430-01, UARIZ-HSC-00142, P01CA041108, 00-0430-01, NCT00078897
|
|
2.
|
Phase: Phase III Type: Natural history/Epidemiology, Prevention Status: Active Age: 50 and over Sponsor: NCI Protocol IDs: SWOG-S0000D, S0000D, NCT00706121
|
|
3.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NSABP-P-5, NSABP P-5, NCT01011478
|
|
4.
|
Phase: Phase III Type: Prevention Status: Active Age: 10 to 17 Sponsor: Pharmaceutical / Industry Protocol IDs: A3191193, MDA-2006-0040, PFIZER-A3191193, N01-CN-05126-2, NCT00393016, NCT00585312
|
|
5.
|
Phase: Phase III Type: Prevention Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: S0820, U10CA037429, NCT01349881
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: CPP-FAP-310, NCT01483144
|
|
7.
|
Phase: Phase II Type: Prevention Status: Active Age: 16 and over Sponsor: Other Protocol IDs: 23266, KUN 2003-2911, NCT00319007
|
|
8.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NCI 06-8-01, P30CA060553, NU-NWU06-8-01, NWU06-8-01, NCT00828984
|
|
9.
|
Phase: Phase II Type: Prevention Status: Active Age: 40 to 70 Sponsor: NCI, Other Protocol IDs: PRO07030214, NIH grant 5P01 CA73743-08, NCT00773097
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention Status: Active Age: 40 to 120 Sponsor: NCI Protocol IDs: NCI-2009-01192, R01CA113681, MC054A, NCT00983580
|
|
11.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 69 Sponsor: NCI, Other Protocol IDs: 00039278, P01CA073992, NCT01187901
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 35 to 80 Sponsor: NCI, Other Protocol IDs: UCI 10-31, NIH, UCI09-13-01, NCT01312467
|
|
13.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 50 to 80 Sponsor: Other Protocol IDs: MIRACLE, NCT01360320
|
|
14.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 40 and over Sponsor: NCI Protocol IDs: MAYO-MC084C, MC084C, R01-CA-132991
|
|
15.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 40 to 79 Sponsor: NCI, Other Protocol IDs: 11165, R01CA160938, NCT01661764
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000648267, LRI-UL-CURCUMIN, EUDRACT-2007-001971-13, EU-20961, UL-CURCUMIN, NCT00973869
|
|
17.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NU-NWU09-13-02, NWU09-13-02, NCT01111292
|
|
18.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 40 to 85 Sponsor: Other Protocol IDs: 100106, NCT01105169
|
|
19.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 40 to 70 Sponsor: Other Protocol IDs: PHO-0702, NCT01127867
|
|
20.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 50 and over Sponsor: Other Protocol IDs: 2008-1122, NCT01211561
|
|
21.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention, Screening Status: Active Age: 50 to 75 Sponsor: NCI, Other Protocol IDs: P01 CA090890, NCT01344330
|
|
22.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 40 to 75 Sponsor: Other Protocol IDs: 2011-1100, NCT01550900
|
|
23.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Approved-not yet active Age: 20 to 45 Sponsor: Other Protocol IDs: FHCRC IR 7532, NCT01619020
|